Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

BIIB033 single ascending dose study in healthy volunteer subjects
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.
Seeing illness in art and medicine: a patient and printmaker collaboration.
Mycophenolate mofetil therapy in the management of inflammatory bowel disease - A retrospective case series and review.
Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder.
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.
FOCiS 2015 Meeting: Immunology by the Bay
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis.
Recruiting women smokers: the engineering of consent.
Postpartum disease activity and breastfeeding in multiple sclerosis revisited.
Remyelination in experimental models of toxin-induced demyelination.
The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells.
International Society for Neurovascular Disease (ISNVD)
Parenteral Dilantin®
2015 Annual Meeting of the Consortium of the Multiple Sclerosis Centers
Episode 53: Part 1 with Dr. Jonathan Kipnis on the discovery of lymphatic vessels in the meninges
FOCIS 2014: Spotlight on Translational Immunology
Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.
Mycophenolate mofetil in the treatment of multiple sclerosis: A preliminary report.
Episode 45 with Dr. Simon Hametner on the role of iron in MS
12th International Society of Neuroimmunology Congress
Episode 54 with Dr. Jonathan Kipnis: Part 2 on meningeal lymphatic vessels in neuroinflammation, and clinical implications
Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database.
Temporal trends in the incidence of multiple sclerosis: a systematic review.

Pages